You are here

earnings

Novavax is on thin ice, and the latest update isn’t exactly encouraging

Stat

Thu, 02/1/24 - 11:17 am

Roche shares fall on modest 2024 outlook

Reuters

Thu, 02/1/24 - 11:16 am

Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC

Fierce Pharma

Wed, 01/31/24 - 10:27 pm

Novo Nordisk doubles stock of Wegovy starter doses but supply constraints persist: CEO

Fierce Pharma

Wed, 01/31/24 - 11:56 am

GSK sees strong growth as Haleon split and vaccine drive pays off

Reuters

Wed, 01/31/24 - 11:53 am

After Novartis' radiotherapy Pluvicto disappoints, CEO touts 'compelling case' for future growth

Fierce Pharma

Wed, 01/31/24 - 11:38 am

Pfizer posts surprise 4th quarter profit, but key products miss on sales

Reuters

Tue, 01/30/24 - 11:11 am

Novo Nordisk Puts Pharma Peers in the Shade as Key Earnings Reports Awaited

Yahoo/Bloomberg

Sun, 01/28/24 - 06:27 pm

Abbott forecasts 2024 earnings largely below estimates, shares down

Reuters

Wed, 01/24/24 - 09:33 am

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

CNBC

Tue, 01/23/24 - 10:45 am

Masimo’s preliminary Q4 results, 2024 outlook exceed analyst expectations

Medtech Dive

Fri, 01/12/24 - 09:58 am

Q3 recap: Medtech firms grapple with layoffs, GLP-1s and China slowdown

Medtech Dive

Mon, 11/20/23 - 11:30 am

Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit

Fierce Pharma

Mon, 11/13/23 - 11:52 am

Teva Pharmaceutical

Illumina cuts annual profit forecast for second straight quarter

Yahoo/Reuters

Thu, 11/9/23 - 11:36 pm

AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug

Fierce Biotech

Thu, 11/9/23 - 09:58 am

sickle cell disease

Novavax posts higher-than-expected revenue, says prepared to further cut costs

Reuters

Thu, 11/9/23 - 09:45 am

Teva Pharma Makes A Bullish Move After Quarterly Beat, Business Separation Plans

Investors Business Daily

Wed, 11/8/23 - 10:01 pm

Teva Pharmaceutical

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches

Fierce Pharma

Wed, 11/8/23 - 12:10 pm

Chris Viehbacher

Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat

Investors Business Daily

Wed, 11/8/23 - 11:39 am

Gilead Sciences

Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut

Reuters

Wed, 11/8/23 - 11:35 am

Alzheimer's disease

Pages